secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001104659-22-068334
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix appoints Karen A. Flynn to Board of Directors effective June 6, 2022
------------------------------------------------------------------------------

- Appointed Karen A. Flynn as Class I director, term through 2024 annual meeting.
- Initial equity award valued at $400,000: 60% stock options, 40% RSUs, vesting over three years.
- Flynn is SVP and Chief Commercial Officer of Catalent Pharma Solutions (NYSE: CTLT).
- No family relationships or arrangements with other directors/officers disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000110465922068334/0001104659-22-068334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000110465922068334/tm2217713d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-068334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer